dacuronium (dacuronium bromide)

Subscribe to Selected New Research on dacuronium

3 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd without isomeric designation; structure

Also Known As:

dacuronium bromide; Gestormone; Mercilon; Organon N.B.68; dacuronium dibromide, (3alpha)-isomer; dacuronium dibromide, (3beta)-isomer; 2 beta,16 beta-dipiperidino-5 alpha-androstane-17 beta-diol 3 alpha-acetato dimethobromide

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Related Diseases

1.	Hemorrhage 02/01/1994 - "The OC with low dose ethinyl estradiol (20 mcg) (Mercilon) has as low a bleeding rate as does the OC, Varnoline (30 mcg)" 11/01/1992 - "Mercilon is the only oral contraceptive containing 20 micrograms ethinyloestradiol to have high efficacy, to have no adverse pharmacodynamic effects and, importantly, to produce an acceptable bleeding pattern not significantly different from that of oral contraceptives with a higher content of ethinyloestradiol." Get all the results and reference details, order at left...
2.	Ovarian Cysts (Ovarian Cyst) 06/01/1995 - "No one in the Mercilon group developed a follicle larger than 35 mm in diameter that remained for more than 4 weeks (i.e., ovarian cyst)" Get all the results and reference details, order at left...
3.	Cysts 06/01/1995 - "These findings suggest that the type and dose of progestogen in the Mercilon OC (desogestrel) were responsible for the lower frequency of ovarian follicles and cysts in the lower-dose OC group than that in the higher-dose OC." Get all the results and reference details, order at left...
3 Diseases and 3 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Ethinyl Estradiol (Estinyl)
2.	Desogestrel
3.	Oral Contraceptives
4.	Oviol (Mircette)
4 Drugs and Important Bio-Agents and 3 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>